Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: Virologic, immunologic, and morphologic changes - A 96-week analysis

Anton L. Pozniak, Joel E. Gallant, Edwin DeJesus, Jose R. Arribas, Brian Gazzard, Rafael E. Campo, Shan Shan Chen, Damian McColl, Jeffrey Enejosa, John J. Toole, Andrew K. Cheng

Research output: Contribution to journalArticlepeer-review

198 Scopus citations

Fingerprint

Dive into the research topics of 'Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients: Virologic, immunologic, and morphologic changes - A 96-week analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences